(AXSM) Axsome Therapeutics - Performance 52.2% in 12m
Compare AXSM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
38.43%
#31 in Group
Rel. Strength
90.05%
#795 in Universe
Total Return 12m
52.24%
#23 in Group
Total Return 5y
22.43%
#52 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -2.52%
17th Percentile in Group
12m Total Return: AXSM (52.2%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: AXSM vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for AXSM
Total Return (including Dividends) | AXSM | XLV | S&P 500 |
---|---|---|---|
1 Month | -3.72% | -3.79% | -0.87% |
3 Months | 5.48% | -3.99% | -7.58% |
12 Months | 52.24% | 1.72% | 11.88% |
5 Years | 22.43% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | AXSM | XLV | S&P 500 |
1 Month | 31.0% | -3.2% | 23% |
3 Months | -59.9% | -71.4% | -88.5% |
12 Months | 87.7% | -17.5% | 55.1% |
5 Years | 46.9% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #116 | 0.08% | -2.88% |
3 Month | #37 | 9.86% | 14.1% |
12 Month | #23 | 49.7% | 36.1% |
5 Years | #54 | -21.2% | -41.8% |
FAQs
Does AXSM Axsome Therapeutics outperforms the market?
Yes,
over the last 12 months AXSM made 52.24%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months AXSM made 5.48%, while XLV made -3.99%.
Over the last 3 months AXSM made 5.48%, while XLV made -3.99%.
Performance Comparison AXSM vs Indeces and Sectors
AXSM vs. Indices AXSM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 4.16% | -2.85% | 28.0% | 40.4% |
US NASDAQ 100 | QQQ | 3.13% | -5.12% | 27.6% | 39.6% |
US Dow Jones Industrial 30 | DIA | 5.10% | -0.54% | 28.1% | 43.0% |
German DAX 40 | DAX | 5.39% | -5.04% | 8.47% | 27.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | 8.12% | -0.90% | 31.0% | 46.3% |
Hongkong Hang Seng | HSI | 5.15% | -3.78% | 26.1% | 38.4% |
India NIFTY 50 | INDA | 7.0% | -7.78% | 27.7% | 49.2% |
Brasil Bovespa | EWZ | 4.96% | -8.32% | 24.3% | 58.1% |
AXSM vs. Sectors AXSM is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 3.91% | -2.67% | 21.9% | 28.3% |
Consumer Discretionary | XLY | 4.08% | -3.62% | 25.5% | 38.9% |
Consumer Staples | XLP | 7.66% | -3.92% | 22.7% | 41.0% |
Energy | XLE | 8.64% | 10.1% | 33.8% | 63.3% |
Financial | XLF | 5.55% | -1.61% | 20.4% | 29.6% |
Health Care | XLV | 4.24% | 0.07% | 29.7% | 50.5% |
Industrial | XLI | 3.74% | -3.83% | 27.3% | 42.7% |
Materials | XLB | 4.77% | -1.29% | 35.4% | 55.8% |
Real Estate | XLRE | 5.68% | -2.41% | 28.9% | 34.2% |
Technology | XLK | 1.71% | -5.41% | 31.3% | 44.5% |
Utilities | XLU | 7.0% | -3.78% | 25.9% | 30.4% |
Aerospace & Defense | XAR | 3.21% | -10.1% | 14.5% | 25.7% |
Biotech | XBI | 2.86% | -6.0% | 40.6% | 54.1% |
Homebuilder | XHB | 4.85% | -1.45% | 42.8% | 59.3% |
Retail | XRT | 5.73% | -3.16% | 33.6% | 55.0% |